Captopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: Evaluation of main effects of several formulation variables

International Journal of Pharmaceutics

Volumn 193, Issue 2, 2000, Pages 147-156

  Khan, M A ^a,b   Sastry, S V ^c   Vaithiyalingam, S R ^a   Agarwal, V ^a   Nazzal, S ^a   Reddy, I K ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Yamanouchi Shaklee Pharma   (United States)

Author keywords

Captopril; Experimental design; Formulation variables; Gastrointestinal therapeutic system; Pseudolatex

Indexed keywords

ASCORBIC ACID; CAPTOPRIL; CARBOMER; CARBOPOL 974P; CELLULOSE ACETATE; LATEX; POLYMER; SODIUM CHLORIDE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; HYPERTENSION; OSMOSIS; PRIORITY JOURNAL; STOMACH PH;

ALGORITHMS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; CALIBRATION; CAPTOPRIL; CELLULOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; MODELS, THEORETICAL; OSMOSIS; SOLUBILITY;

EID: 0033988302     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00324-5     Document Type: Article

References (13)

1. Banakar, U.V., 1987. Drug delivery systems of 90's: Innovations in controlled release. Am. Pharm. NS27 (2), 39-48.
2. Chen D., Chen H., Ku H. Degradation rates of captopril in aqueous medium through buffer-catalysis oxidation. Drug Dev. Ind. Pharm. 21(7):1995;781-792.
3. Chiao, C.S.L, Robinson, J.R., 1995. Sustained and controlled-release drug delivery systems. In: A.R. Gennaro (Ed.), Remington's Pharmaceutical Sciences, 19th ed. Mark Publishing Company, Pennsylvania, pp. 1660-1675.
4. Duchin K.L., Singhvi S.M., Willard D.A., Migdalof B.H., McKinstry D.N. Captopril kinetics. Clin. Pharmacol. Therap. 31:1982;452-458.
5. Grass, G.M., Robinson, J.R., 1990. Sustained and controlled-release drug delivery system. In: G.S. Banker, C.T. Rhodes (Eds.), Modern pharmaceutics, 2nd ed., Marcel and Dekker Inc., New York.
6. Jonkman J.H.G. Food interactions with sustained release theophylline preparations: a review. Clin. Pharmacok. 16:1989;162-179.
7. Khan M.A., Karnachi A.A., Singh S.K., Sastry S.V., Kislalioglu S.M., Bolton S. Controlled release coprecipitates: formulation considerations. J. Control Rel. 37:1995;132-141.
8. Khan M.A., Bolton S., Kislalioglu M.S. Optimization of process variables for the preparation of Ibuprofen coprecipitates with Eudragit. Int. J. Pharm. 102:1994;185-191.
9. Martindale, 1977. The extra pharmacopoiea. In: Wade, A. (Ed.), The Pharmaceutical Press, London, pp. 138-139.
10. Murray J. X-Stat, Version 2.02®: Statistical Experimental Design, Data Analysis and Nonlinear Optimization. 1994;John Wiley and Sons, New York.
11. Swanson, D.R., Barclay, B.L., Wong, P.S.L., Theeuwes, F., 1987. Nifedipine gastrointestinal therapeutic systems. Am. J. Med. 83(supplement 6B): 3: 3-9.
12. Theeuwes, 1975. Elementary osmotic pump. J. Pharm. Sci. 64 (12), 1987-1991.
13. Timmins P., Jackson I.M., Wong Y.J. Factors affecting captopril stability in aqueous solution. Int. J. Pharm. 11:1982;329-336.